Goal of ATRA for Acute Myeloid Leukemia (AML)

Goal of All-Trans Retinoic Acid for Acute Myeloid Leukemia

All-Trans Retinoic Acid (ATRA) is a drug derived from vitamin A. Its goal is to put acute promyelocytic leukemia (APL) into remission and keep it there. APL is a rare subtype of acute myeloid leukemia.

ATRA treatment alone can often induce remission. Remission is when you have no symptoms of the disease. But doctors often combine it with chemotherapy or with a drug called Trisenox (arsenic trioxide) for the best results. Doctors may use ATRA again during the maintenance phase for at least one year. The goal of maintenance is to keep you in remission and prevent a relapse.

You take ATRA as a pill. You may receive it along with an anthracycline, a type of chemotherapy drug. An example of this type of drug is Daunomycin (daunorubicin). Or you may get ATRA and arsenic trioxide as treatment for APL. During a later phase of treatment, you may have it combined with chemotherapy drugs, such as 6-MP (6-mercaptopurine) and methotrexate.

 
Today's Interactive Tools

The third-party content provided in the Health Library of phoebeputney.com is for informational purposes only and is not designed to diagnose or treat a health problem or disease, or replace the professional medical advice you receive from your physician. If you or your child has or suspect you may have a health problem, please consult your primary care physician. If you or your child may have a medical emergency, call your doctor or 911 or other emergency health care provider immediately in the United States or the appropriate health agency of your country. For more information regarding site usage, please visit: Privacy Information, Terms of Use or Disclaimer.